Silver lining to U.S. market sell-off: Fundamentals still seem to matter
August 7, 2019Broadcom in advanced talks to buy Symantec’s enterprise business: sources
August 7, 2019Medicare to cover expensive cancer cell therapies
at
The U.S. Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized a decision to cover expensive cancer cell therapies sold by Gilead Sciences Inc and Novartis AG .
Powered by WPeMatico
